Skip to main content
Log in

Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia

  • Review Paper
  • Published:
Angiogenesis Aims and scope Submit manuscript

Abstract

Placental angiogenesis is critical to the success of human pregnancy. Angiogenesis is defined as the formation of new blood vessels from existing vasculature. Angiogenesis is necessary for the establishment of adequate placental perfusion, which is important for providing the optimum in utero environment to support fetal development. Defective placental angiogenesis is associated with several pregnancy complications, the most clinically important of which is preeclampsia; the multisystem disorder is characterized by maternal hypertension, proteinuria, and endothelial dysfunction. Here, we review our current understanding of several key angiogenic factors that are associated with placental angiogenesis. We also discuss their importance with respect to preeclampsia, where aberrant expression and release of these factors into the maternal circulation is thought to contribute to the pathogenesis and pathophysiology of preeclampsia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Aaserud M, Lewin S, Innvaer S, Paulsen E, Dahlgren A, Trommald M, Duley L, Zwarenstein M, Oxman A (2005) Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia. BMC Health Serv Res 5:68

    Article  PubMed Central  PubMed  Google Scholar 

  2. Athanassiades A, Hamilton G, Lala P (1998) Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. Biol Reprod 59(3):643–654

    Article  CAS  PubMed  Google Scholar 

  3. Austgulen R, Lien E, Vince G, Redman C (1997) Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 71(1):53–58

    Article  CAS  PubMed  Google Scholar 

  4. Bauer S, Pollheimer J, Hartmann P, Husslein J, Aplin D, Knofler M (2004) Tumor necrosis factor alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first trimester villous explant cultures. J Clin Endocrinol Metab 89:903–8

  5. Bellamy L, Casas J, Hingorani A, Williams D (2007) Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335(7627):974

    Article  PubMed Central  PubMed  Google Scholar 

  6. Brosens I, Robertson WB, Dixon HG (1967) The physiological response of the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol 2:569–79

  7. Brosens I, Robertson W, Dixon H (1972) The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1:177–191

    CAS  PubMed  Google Scholar 

  8. Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R (2013) Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol 28(1):1–19

    Article  PubMed  Google Scholar 

  9. Bujold E, Morency A, Roberge S, Lacasse Y, Forest J, Gigeure Y (2009) Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynecol Can 31(9):818–826

    Google Scholar 

  10. Chien P, Arnott N, Gordon A, Owen P, Khan K (2000) How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview. BJOG 107(2):196–208

    Article  CAS  PubMed  Google Scholar 

  11. Chaiworapongsa T, Romero R, Savasan ZA, Kusanovic JP, Ogge G, Soto E et al (2011) Maternal plasma concentrations of angiogenic/antiangiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med 24:1187–1207

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Cross J, Werb Z, Fisher S (1994) Implantation and the placenta: key pieces of the development puzzle. Science 266(5190):1508–1518

    Article  CAS  PubMed  Google Scholar 

  13. Dijke P, Goumans M, Pardali E (2008) Endoglin in angiogenesis and vascular diseases. Angiogenesis 11(1):79–89

    Article  CAS  PubMed  Google Scholar 

  14. Duley L (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33(3):130–137

    Article  PubMed  Google Scholar 

  15. Dunk C, Shams M, Nijjar S, Rhaman M, Qiu Y, Bussolati B, Ahmed A (2000) Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol 156:2185–2199

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Geva E, Jaffe R (2000) Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 74(3):429–438

    Article  CAS  PubMed  Google Scholar 

  17. Goksu A, Nazli M, Elis Yildiz S (2012) Significance of platelet endothelial cell adhesion molecule-1 (PECAM-1) and intercellular adhesion molecule-1 (ICAM-1) expressions in preeclamptic placentae. Endocrine 42(1):125–131

    Article  Google Scholar 

  18. Goldenberg R, Culhane J, Iams J, Romero R (2008) Epidemiology and causes of preterm birth. The Lancet 371(9606):75–84

    Article  Google Scholar 

  19. Gude N, Roberts C, Kalionis B, King R (2004) Growth and function of the normal human placenta. Thromb Res 114(5–6):397–407

    Article  CAS  PubMed  Google Scholar 

  20. Harrington KF, Campbell S, Bewley S, Bower S (1991) Doppler velocimetry studies of the uterine artery in the early prediction of pre-eclampsia and intra-uterine growth retardation. Eur J Obstet Gynecol Reprod Biol 42(Suppl.):S14–S20

    PubMed  Google Scholar 

  21. Hoeben A, Landuyt B, Highley M, Wildiers H, Van Oosterom A, De Bruijn E (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56(4):549–580

    Article  CAS  PubMed  Google Scholar 

  22. Irving R, Belton N, Elton R, Walker B (2000) Adult cardiovascular risk factors in premature babies. The Lancet 355(9221):2135–2136

    Article  CAS  Google Scholar 

  23. Kumasawa K, Ikawa M, Kidoya H, Hasuwa H, Saito-Fujita T, Morioka Y, Takakura N, Kimura T, Okabe M (2011) Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc Natl Acad Sci USA 108(4):1451–1455

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Kim YM, Hwang S, Kim Y, Pyun B, Kim T, Lee S, Gho Y, Kwon Y (2002) Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J Biol Chem 277(31):27872–27879

    Article  CAS  PubMed  Google Scholar 

  25. Laskowska M, Laskowska K, Leszczynsak-Gorzelak B, Oleszczuk J (2002) Maternal and umbilical sTNFR-1 in preeclamptic pregnancies with intrauterine normal and intrauterine growth retarded fetus. Hypertens pregnancy 26(1):13–21

    Article  Google Scholar 

  26. Leal A, Poon L, Frivosa V, Veduta A, Nicolaides K (2009) First trimester maternal serum tumour necrosis factor receptor-1 and pre-eclampsia. Ultrasound Obstet Gynecol 33:135–141

    Article  CAS  PubMed  Google Scholar 

  27. Levine R, Lam C, Qian C, Yu K, Maynard S, Sachs B, Sibai B, Epstein F, Romero R, Thadhani R, Karumanchi S (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355(10):992–1005

    Article  CAS  PubMed  Google Scholar 

  28. Linzer D, Fisher S (1999) The placenta and the prolactin family of hormones: regulation of the physiology of pregnancy. Mol Endocrinol 13:837–840

    Article  CAS  PubMed  Google Scholar 

  29. Lockwood C, Oner C, Uz Y, Kayisli U, Huang S, Buchwalkder L, Murk W, Funai E, Schatz F (2008) Matrix metalloproteinase 9 (MMP9) expression in pre-eclamptic decidua and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells. Biol Reprod 78(6):1064–1072

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ (2009) Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 53:944–951

    Article  CAS  PubMed  Google Scholar 

  31. Madazli R, Benian A, Ilvan S, Calay Z (2006) Placental apoptosis and adhesion molecules expression in the placenta and the maternal placental bed of pregnancies complicated by fetal growth restriction with and without pre-eclampsia. J Obstet Gynaecol 26(1):5–10

    Article  CAS  PubMed  Google Scholar 

  32. Maisonpierre P, Suri C, Jones P, Bartunkova S, Wiegand S, Radziejewski C, Compton D (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277(5322):55–60

    Article  CAS  PubMed  Google Scholar 

  33. Maynard S, Epstein F, Karumanchi S (2008) Preeclampsia and angiogenic imbalance. Annu Rev Med 59:61–78

    Article  CAS  PubMed  Google Scholar 

  34. Maynard S, Min J, Lim K, Li J, Mondal S, Libermann T, Morgan J, Sellke F, Stillman I, Epstein F, Sukhatme V, Karumanchi S (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111(5):649–658

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Milner C, Hansen T, Singh H, Brindle N (2009) Roles of the receptor tyrosine kinases Tie-1 and Tie-2 in mediating the effects of angiopoietin-1 on endothelial permeability and apoptosis. Microvasc Res 77:187–191

    Article  CAS  PubMed  Google Scholar 

  36. Mutter W, Karumanchi S (2008). Molecular mechanisms of preeclampsia. Microvasc Res 75(1):1–8

  37. Nisell H, Lintu H, Lunell N, Mollerstrom G, Pettersson E (1995) Blood pressure and renal function seven years after pregnancy complicated by hypertension. Br J Obstet Gynaecol 102(11):876–881

    Article  CAS  PubMed  Google Scholar 

  38. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ (2010) Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 122(5):478–487

    Article  CAS  PubMed  Google Scholar 

  39. Okada Y, Ueshin Y, Isotani A, Saito-Fujita T, Nakashima H, Kimura K, Mizoguchi A, Oh-Hora M, Mori Y, Ogata M, Oshima RG, Okabe M, Ikawa M (2007) Complementation of placental defects and embryonic lethality by trophoblast-specific lentiviral gene transfer. Nat Biotechnol 25(2):233–237

    Article  CAS  PubMed  Google Scholar 

  40. Parra M, Rodrigo R, Barja P, Bosco C, Fernández V, Muñoz H, Soto-Chacón E (2005) Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obstet Gynecol 193:1486–1491

    Article  CAS  PubMed  Google Scholar 

  41. Papageorghiou AT, Yu CK, Cicero S, Bower S, Nicolaides KH (2002) Second-trimester uterine artery Doppler screening in unselected populations: a review. J Matern Fetal Neonatal Med 12:78–88

    Article  CAS  PubMed  Google Scholar 

  42. Pijnenborg R, Dixon G, Robertson W, Brosens I (1980) Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1(1):3–19

    Article  CAS  PubMed  Google Scholar 

  43. Pollheimer J, Bauer S, Huber A, Husslein P, Aplin J, Knofler M (2004) Expression patterns of collagen XVIII and its cleavage product, the angiogenesis inhibitor endostatin, at the fetal–maternal interface. Placenta 25:770–779

    Article  CAS  PubMed  Google Scholar 

  44. Pollheimer J, Haslinger P, Fock V, Prast J, Saleh L, Biadasiewicz K, Jetne-Delmann R, Haraldsen G, Haider S, Hirtenlehner-Ferber K, Knofler M (2011) Endostatin suppresses IGF-II-mediated signaling and invasion of human extravillous trophoblasts. Endocrinology 152(11):4431–4442

    Article  CAS  PubMed  Google Scholar 

  45. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH (2011) First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 53:812–818

  46. Poon IK, Patel KK, Davis DS, Parish CR, Hulett MD (2011). Histidine-rich glycoprotein: the swiss army knife of mammalian plasma. Blood 117(7):2093–101

  47. Powe CE, Levine RJ, Karumanchi SA (2011) Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123(24):2856–2869

    Article  PubMed  Google Scholar 

  48. Qin L, Xiyun Y, Yang L, Ying Z, Xingang Z, Yi S (2003) Pre-eclampsia is associated with the failure of melanoma cell adhesion molecule (MCAM/CD146) expression by intermediate trophoblast. Laboratory Investigation 84(2):221–8

  49. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA (2005) Cardiovascular Health After Maternal Placental Syndromes (CHAMPS): population-based retrospective cohort study. The Lancet 366:1797–1803

    Article  Google Scholar 

  50. Reith A, Booth N, Moore N, Cruickshank D, Bennett B (1993) Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hyatidiform mole. Br J Obstet Gynaecol 100(4):370–374

    Article  CAS  PubMed  Google Scholar 

  51. Roberge S, Demers S, Bujold E (2013) Initiation of aspirin in early gestation for the prevention of pre-eclampsia. BJOG 120(6):773–774

    Article  CAS  PubMed  Google Scholar 

  52. Roberts J, Cooper D (2001) Pathogenesis and genetics of pre-eclampsia. The Lancet 357:53–56

    Article  CAS  Google Scholar 

  53. Roberts J, Taylor R, Musci T, Rodgers G, Hubel C, McLaughlin M (1989) Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161(5):1200–1204

    Article  CAS  PubMed  Google Scholar 

  54. Romero R, Nien J, Espinoza J, Todem D, Fu W, Chung H, Karumanchi S (2008) A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. Journal of Maternal-Fetal and Neonatal Medicine 21(1):9–23

  55. Romo A, Carceller R, Tobajas J (2009) Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr Endocrinol Rev 6(3):332–336

    PubMed  Google Scholar 

  56. Said J, Dekker G (2003) Pre-eclampsia and thrombophilia. Best Pract Res Clin Obstet Gynaecol 17(3):441–458

    Article  PubMed  Google Scholar 

  57. Schlembach D, Wallner W, Sengenberger R, Stiegler E, Mortl M, Beckmann MW, Lang U (2007) Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 29:407–413

    Article  CAS  PubMed  Google Scholar 

  58. Shibuya M, Claesson-Welsh L (2006) Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 312:549–560

    Article  CAS  PubMed  Google Scholar 

  59. Shin S, Lee SH, Park S, Kang SM, Chung N, Shim WH, Cho SY, Manabe I, Jang Y (2010) Soluble fms-like tyrosine kinase-1 and the progression of carotid intima-media thickness: 24-month follow-up study. Circ J 74:2211–2215

    Article  CAS  PubMed  Google Scholar 

  60. Seval Y, Sati L, Celik-Ozenci C, Taskin O, Demir R (2008) The distribution of angiopoietin-1, angiopoietin-2 and their receptors tie-1 and tie-2 in the very early human placenta. Placenta 29(9):809–815

    Article  CAS  PubMed  Google Scholar 

  61. Sibai B (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102(1):181–192

    Article  PubMed  Google Scholar 

  62. Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. The Lancet 365(9461):785–799

    Article  Google Scholar 

  63. Sibai B, Ewell M, Levine R, Klebanoff M, Exterlitz J, Catalano P, Goldenberg R, Joffe G (1997) Risk factors associated with preeclampsia in healthy nulliparous women. Am J Obstet Gynecol 177(5):1003–1010

    Article  CAS  PubMed  Google Scholar 

  64. Smith G, Pell J, Walsh D (2001) Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births. The Lancet 357(9273):2002–2006

    Article  CAS  Google Scholar 

  65. Soker S, Takashima S, Miao H, Neufeld G, Klagsbrun M (1998) Neuropillin-1 is expressed by endothelial and tumour cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:725–745

    Article  Google Scholar 

  66. Spencer K, Yu CKH, Savvidou M, Papageorghiou AT, Nicolaides KH (2006) Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free β-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks’ gestation. Ultrasound Obstet Gynecol 27:658–663

    Article  CAS  PubMed  Google Scholar 

  67. St-Jacques S, Forte M, Lye S, Letarte M (1994) Localization of endoglin, a transforming growth factor-beta binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol Reprod 51(3):405–413

    Article  CAS  PubMed  Google Scholar 

  68. Stepan H, Unversucht A, Wessel N, Faber R (2007) Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 49:818–824

    Article  CAS  PubMed  Google Scholar 

  69. Stepan H, Geipel A, Schwarz F, Kramer T, Wessel N, Faber R (2008) Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion. Am J Obstet Gynecol 198(175):e1–e6

    PubMed  Google Scholar 

  70. Thadhani R, Kisner T, Hagmann H, Bossung V, Noack S, Schaarschmidt W, Jank A, Kribs A, Cornely OA, Kreyssig C, Hemphill L, Rigby AC, Khedkar S, Lindner TH, Mallmann P, Stepan H, Karumanchi SA, Benzing T (2011) Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 124(8):940–950

    Article  CAS  PubMed  Google Scholar 

  71. Tziotis J, Malamitsi-Puchner A, Vlachos G, Creatsas G, Michalas S (2002) Adhesion molecule expression in the placental bed of pregnancies with pre-eclampsia. BJOG 109(2):197–201

    Article  PubMed  Google Scholar 

  72. Van Wiijk M, Kublickiene K, Boer K, VanBavel E (2000) Vascular function in preeclampsia. Cardiovasc Res 47(1):38–48

    Article  Google Scholar 

  73. Venkatesha S, Toporsian M, Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim Y, Bdolah Y, Lim K, Yuan H, Libermann T, Stillman I, Roberts D, D’Amore P, Epstein F, Sellke F, Romero R, Sukhatme V, Letarte M, Karumanchi S (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12(6):642–649

    Article  CAS  PubMed  Google Scholar 

  74. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H et al (2012) The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 206(58):e1–e8

    PubMed  Google Scholar 

  75. Wang Y, Walsh S (1996) TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 32:157–169

    Article  CAS  PubMed  Google Scholar 

  76. Wathen K, Ylikorkala O, Andersson S, Alfthan H, Stenman U, Vuorela P (2009) Maternal serum endostatin at gestational weeks 16–20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation. Acta Obstet Gynecol Scand 88(5):593–598

    Article  CAS  PubMed  Google Scholar 

  77. Wilson B, Watson M, Prescott G, Sunderland S, Campbell D, Hannaford P, Smith W (2003) Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 326(7394):845

    Article  PubMed Central  PubMed  Google Scholar 

  78. Zhang J, Zeisler J, Hatch M, Berkowitz G (1997) Epidemiology of pregnancy-induced hypertension. Epidemiol Rev 19(2):218–232

    Article  CAS  PubMed  Google Scholar 

  79. Zhou Y, Damsky C, Fischer S (1997) Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 99(9):2152–2164

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  80. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitallo K, Damsky C, Fisher S (2002) Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160(4):1405–1423

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Padma Murthi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pratt, A., Da Silva Costa, F., Borg, A.J. et al. Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia. Angiogenesis 18, 115–123 (2015). https://doi.org/10.1007/s10456-014-9452-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10456-014-9452-3

Keywords

Navigation